Interestingly, further studies have shown that TRIM44 activates the AKT/mTOR signal pathway, the FOXM1–EZH2 signaling pathway, and extracellular matrix remodeling in cancer progression, DNA damage repair, and autophagy [178–183]. This evidence concerns the gene AKT1 and cancer.